• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    Stemline Therapeutics, Inc. (STML)

    -NasdaqCM
    13.05 Down 0.20(1.51%) May 22, 4:00PM EDT
    Add to Portfolio
    Prev Close:13.25
    Open:13.10
    Bid:N/A
    Ask:13.61 x 200
    1y Target Est:41.50
    Beta:-1.92
    Earnings Date:Aug 12 - Aug 17 (Est.)
    Day's Range:12.80 - 13.35
    52wk Range:10.50 - 18.94
    Volume:89,962
    Avg Vol (3m):112,456
    Market Cap:233.69M
    P/E (ttm):N/A
    EPS (ttm):-2.23
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for STML

    Comparison

    Symbol% ChgMkt Cap
    STMLDown 1.51%233.69M
    OMEDUp 0.70%690.12M
    VSTMUp 2.97%311.73M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):513.78
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.89
    Quarterly EPS Est (Jun-15) :-0.45
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Stemline Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, acquisition, development, and commercialization of proprietary therapeutics for cancer stem cells and bulk tumors in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback